Yüklüyor......
A Bayesian Adaptive Phase I-II Clinical Trial for Evaluating Efficacy and Toxicity with Delayed Outcomes
BACKGROUND: In traditional phase I oncology trials, the safety of a new chemotherapeutic agent is tested in a dose escalation study to identify the maximum tolerated dose, which is defined as the highest dose with acceptable toxicity. An alternate approach is to jointly model toxicity and efficacy a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946437/ https://ncbi.nlm.nih.gov/pubmed/24082004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774513500589 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|